Go to homepage

Published: 2023 | Last reviewed: May 2026

Bioreactor Design for Cell Therapy Manufacturing: Closed System Requirements

The transition from traditional open-flask culture to closed-system bioreactor manufacturing represents a critical evolution in cell therapy production, enabling the scalability, reproducibility, and contamination control necessary for commercial success. At Cytion, we understand that bioreactor technology must address the unique challenges of living therapeutic products: maintaining cell viability and potency throughout extended culture, providing precise environmental control, enabling aseptic operation from inoculation through harvest, and facilitating regulatory compliance through comprehensive process monitoring and documentation. Unlike microbial fermentation or recombinant protein production in robust cell lines, therapeutic cell manufacturing with primary cells, Stem Cells, or genetically modified cells demands gentler culture conditions, more sophisticated nutrient management, and rigorous quality control to preserve the biological functions that define therapeutic efficacy. Closed-system design minimizes contamination risk while enabling automation, reducing operator variability and labor costs that currently constrain cell therapy accessibility.

Bioreactor Type Culture Mode Scale Range Best Applications
Stirred-tank (microcarrier) Suspension (adherent cells on beads) 50 mL - 2000 L MSCs, adherent cell expansion
Hollow fiber Perfusion (cells in intracapillary space) 10 mL - 2 L High-density culture, exosome production
Wave/rocking platform Suspension in disposable bags 2 L - 500 L T-cells, suspension cell expansion
Fixed-bed Adherent on packed scaffolds 100 mL - 10 L MSCs, anchorage-dependent cells
Gas-permeable (G-Rex) Static adherent or suspension 100 mL - 5 L T-cells, minimal agitation needs

Fundamental Design Requirements for Therapeutic Cell Culture

Stirred-Tank Bioreactors with Microcarrier Technology

Hollow Fiber Bioreactor Systems for High-Density Culture

Bioreactor Design for Cell Therapy Manufacturing: Closed System Requirements

See article content above and below for detailed information.

Wave and Rocking Platform Bioreactors

Process Analytical Technology and Automation Integration

Scalability Considerations and Tech Transfer Challenges

Closed-System Components and Sterile Connectivity

Quality by Design and Regulatory Compliance

We have detected that you are in a different country or are using a different browser language than currently selected. Would you like to accept the suggested settings?

Close